Study Stopped
difficulties of recruitment
Effect of Intermittent ThetaBurst Stimulation in Treatment-resistant Bipolar Depression
iTBS-BIP
Effects of Intermittent Theta Burst Stimulation Applied Over the Left Dorsolateral Prefrontal Cortex in Patients With Treatment-resistant Bipolar Depression
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
The aim is to evaluate the evaluate the clinical interest and the safety of repetitive transcranial magnetic stimulation (rTMS) delivered as intermittent Theta burst stimulation(iTBS) on severity of depression in patients with treatment-resistant bipolar disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2011
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 6, 2016
CompletedFirst Posted
Study publicly available on registry
April 15, 2016
CompletedAugust 2, 2018
July 1, 2018
1 month
April 6, 2016
July 31, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Beck Depression Inventory
Self-reported clinical scale with 13 items
2 time point measure, before and after the end of stimulation sessions (changes from baseline BDI scores at 6 weeks)
Study Arms (2)
active iTBS
ACTIVE COMPARATORParticipants will receive 10 to 30 sessions of active intermittent theta burst stimulation (iTBS) consisting in delivering 2 s train of bursts containing three pulses at 50 Hz repeated each 200 ms every 10 s (iTBS). Each iTBS session contained 990 pulses and lasted 6 min. Stimulation intensity will be set at 80% of the patient's resting motor threshold. iTBS will be applied twice per day, with at least three hours between each session. Ten to 30 sessions will be delivered until patient achieved remission (i.e., 13-item Beck Depression Inventory (BDI13) score \< 10). iTBS will be applied over the left dorsolateral prefrontal cortex (DLPFC) according to the individual's 3D-T1 MRI.
sham iTBS
SHAM COMPARATORThe same protocol (location, intensity, parameters of stimulation) will be applied using a commercial sham coil.
Interventions
Transcranial magnetic stimulation. MagProX100 (MagVenture, Denmark) with a figure-eight coil (MCF-B65)
Transcranial magnetic stimulation. MagProX100 (MagVenture, Denmark) with a sham figure-eight coil (MCF-P-B65)
Eligibility Criteria
You may qualify if:
- Bipolar disorder according to Diagnostic and Statistical Manual of Mental Disorders, DSM-IV criteria
- Montgomery and Asberg depression scale \> 20
You may not qualify if:
- other psychiatric features, rapid cycles
- Benzodiazepines intake
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Szekely, MD
University Hospital, Grenoble
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 6, 2016
First Posted
April 15, 2016
Study Start
January 1, 2011
Primary Completion
February 1, 2011
Study Completion
January 1, 2015
Last Updated
August 2, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share